Skip to main content
Erschienen in: Strahlentherapie und Onkologie 3/2021

02.06.2020 | Original Article

Evaluation of automatic VMAT plans in locally advanced nasopharyngeal carcinoma

verfasst von: Quanbin Zhang, Liya Ou, Yingying Peng, Hui Yu, Linjing Wang, Shuxu Zhang

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aimed to evaluate the quality of locally advanced nasopharyngeal carcinoma (NPC) radiotherapy plans generated by the automated planning module of a commercial treatment planning system (TPS).

Methods

Data of 30 patients with locally advanced NPC were retrospectively investigated. For each patient, volumetric modulated arc therapy (VMAT) plans with double arcs were generated manually by experienced physicists and automatically in the Pinnacle3 Auto-Planning module (Philips Medical Systems, Fitchburg, WI, USA). The anatomic distance between the second clinical target volume (CTV2) and the pons of the brainstem, and the T category of disease were factored into the evaluation. Dosimetric verification was evaluated in terms of gamma pass rate. Target coverage, sparing of organs at risk (OARs), and monitor units were evaluated and compared between the manual and automatic VMAT plans.

Results

Not all treatment plans fully met the dose objectives for planning target volumes (PTVs) and OARs, particularly in T4 patients. Overall, automatic VMAT provides a comparable or superior plan quality to manual VMAT in most cases. In stratified analysis, plan quality is mainly independent on T category but is also affected by anatomic distance. If the anatomic distance is less than 5 mm, the automatic VMAT plan quality is equal or even inferior to manual VMAT performed by experienced physicists. Conversely, if the anatomic distance is greater than 5 mm, the automatic VMAT plan quality is superior to manual VMAT. Gamma pass rates for quality assurance are similar between manual and automatic VMAT plans for the former case, but significantly higher in automatic VMAT for the latter.

Conclusion

The selection of manual versus automatic VMAT planning in locally advanced NPC should be made individually based on the anatomic distance, rather than blindly and habitually, since automatic VMAT is not good enough to completely replace manual VMAT.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lu SH, Cheng JH, Kuo SH, Lee JS, Chen LH, Wu JK et al (2012) Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT. Radiother Oncol 104(3):324–330CrossRef Lu SH, Cheng JH, Kuo SH, Lee JS, Chen LH, Wu JK et al (2012) Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT. Radiother Oncol 104(3):324–330CrossRef
2.
Zurück zum Zitat Sun Y, Guo R, Yin WJ, Tang LL, Yu XL, Chen M et al (2013) Which T category of nasopharyngeal carcinoma may benefit most from volumetric modulated arc therapy compared with step and shoot intensity modulated radiation therapy. Plos One 8(9):e75304CrossRef Sun Y, Guo R, Yin WJ, Tang LL, Yu XL, Chen M et al (2013) Which T category of nasopharyngeal carcinoma may benefit most from volumetric modulated arc therapy compared with step and shoot intensity modulated radiation therapy. Plos One 8(9):e75304CrossRef
3.
Zurück zum Zitat Verbakel WF, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S (2009) Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys 74(1):252–259CrossRef Verbakel WF, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S (2009) Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys 74(1):252–259CrossRef
4.
Zurück zum Zitat Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH et al (2004) Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60(5):1440–1450CrossRef Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH et al (2004) Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60(5):1440–1450CrossRef
5.
Zurück zum Zitat Lee TF, Chao PJ, Ting HM, Lo SH, Wang YW, Tuan CC et al (2011) Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma. J Appl Clin Med Phys 12(4):158–174CrossRef Lee TF, Chao PJ, Ting HM, Lo SH, Wang YW, Tuan CC et al (2011) Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma. J Appl Clin Med Phys 12(4):158–174CrossRef
6.
Zurück zum Zitat Ning ZH, Mu JM, Jin JX, Li XD, Li QL, Gu WD et al (2013) Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy. Radiat Oncol 8(1):237CrossRef Ning ZH, Mu JM, Jin JX, Li XD, Li QL, Gu WD et al (2013) Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy. Radiat Oncol 8(1):237CrossRef
7.
Zurück zum Zitat Tol JP, Delaney AR, Dahele M, Slotman BJ, Verbakel WF (2015) Evaluation of a knowledge-based planning solution for head and neck cancer. Int J Radiat Oncol Biol Phys 91(3):612–620CrossRef Tol JP, Delaney AR, Dahele M, Slotman BJ, Verbakel WF (2015) Evaluation of a knowledge-based planning solution for head and neck cancer. Int J Radiat Oncol Biol Phys 91(3):612–620CrossRef
8.
Zurück zum Zitat Song Y, Wang Q, Jiang X, Zhang Y, Bai S (2016) Fully automatic volumetric modulated arc therapy plan generation for rectal cancer. Radiother Oncol 119(3):531–536CrossRef Song Y, Wang Q, Jiang X, Zhang Y, Bai S (2016) Fully automatic volumetric modulated arc therapy plan generation for rectal cancer. Radiother Oncol 119(3):531–536CrossRef
9.
Zurück zum Zitat Wang J, Chen Z, Li W, Qian W, Wang X, Hu W (2018) A new strategy for volumetric-modulated arc therapy planning using AutoPlanning based multicriteria optimization for nasopharyngeal carcinoma. Radiat Oncol 13(1):94CrossRef Wang J, Chen Z, Li W, Qian W, Wang X, Hu W (2018) A new strategy for volumetric-modulated arc therapy planning using AutoPlanning based multicriteria optimization for nasopharyngeal carcinoma. Radiat Oncol 13(1):94CrossRef
10.
Zurück zum Zitat Speer S, Klein A, Kober L, Weiss A, Yohannes I, Bert C (2017) Automation of radiation treatment planning. Strahlenther Onkol 193(8):656–665CrossRef Speer S, Klein A, Kober L, Weiss A, Yohannes I, Bert C (2017) Automation of radiation treatment planning. Strahlenther Onkol 193(8):656–665CrossRef
11.
Zurück zum Zitat Zhang Q, Peng Y, Song X, Yu H, Wang L, Zhang S (2020) Dosimetric evaluation of automatic and manual plans for early nasopharyngeal carcinoma to radiotherapy. Med Dosim 45(1):e13–e20CrossRef Zhang Q, Peng Y, Song X, Yu H, Wang L, Zhang S (2020) Dosimetric evaluation of automatic and manual plans for early nasopharyngeal carcinoma to radiotherapy. Med Dosim 45(1):e13–e20CrossRef
12.
Zurück zum Zitat Krayenbuehl J, Norton I, Studer G, Guckenberger M (2015) Evaluation of an automated knowledge based treatment planning system for head and neck. Radiat Oncol 10(1):226CrossRef Krayenbuehl J, Norton I, Studer G, Guckenberger M (2015) Evaluation of an automated knowledge based treatment planning system for head and neck. Radiat Oncol 10(1):226CrossRef
13.
Zurück zum Zitat Fogliata A, Belosi F, Clivio A, Navarria P, Nicolini G, Scorsetti M et al (2014) On the pre-clinical validation of a commercial model-based optimisation engine: application to volumetric modulated arc therapy for patients with lung or prostate cancer. Radiother Oncol 113(3):385–391CrossRef Fogliata A, Belosi F, Clivio A, Navarria P, Nicolini G, Scorsetti M et al (2014) On the pre-clinical validation of a commercial model-based optimisation engine: application to volumetric modulated arc therapy for patients with lung or prostate cancer. Radiother Oncol 113(3):385–391CrossRef
14.
Zurück zum Zitat Hussein M, South CP, Barry MA, Adams EJ, Jordan TJ, Stewart AJ et al (2016) Clinical validation and benchmarking of knowledge-based IMRT and VMAT treatment planning in pelvic anatomy. Radiother Oncol 120(3):473–479CrossRef Hussein M, South CP, Barry MA, Adams EJ, Jordan TJ, Stewart AJ et al (2016) Clinical validation and benchmarking of knowledge-based IMRT and VMAT treatment planning in pelvic anatomy. Radiother Oncol 120(3):473–479CrossRef
15.
Zurück zum Zitat Hansen CR, Nielsen M, Bertelsen AS, Hazell I, Holtved E, Zukauskaite R et al (2017) Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer. Acta Oncol 56(11):1495–1500CrossRef Hansen CR, Nielsen M, Bertelsen AS, Hazell I, Holtved E, Zukauskaite R et al (2017) Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer. Acta Oncol 56(11):1495–1500CrossRef
16.
Zurück zum Zitat Delaney AR, Dahele M, Tol JP, Slotman BJ, Verbakel WF (2017) Knowledge-based planning for stereotactic radiotherapy of peripheral early-stage lung cancer. Acta Oncol 56(3):490–495CrossRef Delaney AR, Dahele M, Tol JP, Slotman BJ, Verbakel WF (2017) Knowledge-based planning for stereotactic radiotherapy of peripheral early-stage lung cancer. Acta Oncol 56(3):490–495CrossRef
17.
Zurück zum Zitat Wang J, Hu W, Yang Z, Chen X, Wu Z, Yu X et al (2017) Is it possible for knowledge-based planning to improve intensity modulated radiation therapy plan quality for planners with different planning experiences in left-sided breast cancer patients? Radiat Oncol 12(1):85CrossRef Wang J, Hu W, Yang Z, Chen X, Wu Z, Yu X et al (2017) Is it possible for knowledge-based planning to improve intensity modulated radiation therapy plan quality for planners with different planning experiences in left-sided breast cancer patients? Radiat Oncol 12(1):85CrossRef
18.
Zurück zum Zitat Ferris MJ, Zhong J, Switchenko JM, Higgins KA, Cassidy RJ III, McDonald MW et al (2018) Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. Radiother Oncol 126(1):100–106CrossRef Ferris MJ, Zhong J, Switchenko JM, Higgins KA, Cassidy RJ III, McDonald MW et al (2018) Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. Radiother Oncol 126(1):100–106CrossRef
19.
Zurück zum Zitat Kamal M, Rosenthal DI, Batra A, Volpea S, Elgohari B, Goepfert RP et al (2019) Fatigue following radiation therapy in nasopharyngeal cancer survivors: a dosimetric analysis incorporating patient report and observer rating. Radiother Oncol 133:35–42CrossRef Kamal M, Rosenthal DI, Batra A, Volpea S, Elgohari B, Goepfert RP et al (2019) Fatigue following radiation therapy in nasopharyngeal cancer survivors: a dosimetric analysis incorporating patient report and observer rating. Radiother Oncol 133:35–42CrossRef
20.
Zurück zum Zitat Paddick I (2000) A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg 93(Suppl 3):219–222CrossRef Paddick I (2000) A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg 93(Suppl 3):219–222CrossRef
21.
Zurück zum Zitat Kataria T, Sharma K, Subramani V, Karrthick KP, Bisht SS (2012) Homogeneity Index: an objective tool for assessment of conformal radiation treatments. J Med Phys 37(4):207–213CrossRef Kataria T, Sharma K, Subramani V, Karrthick KP, Bisht SS (2012) Homogeneity Index: an objective tool for assessment of conformal radiation treatments. J Med Phys 37(4):207–213CrossRef
22.
Zurück zum Zitat Bohsung J, Gillis S, Arrans R, Bakai A, De Wagter C, Knöös T et al (2005) IMRT treatment planning—a comparative inter-system and inter-centre planning exercise of the ESTRO QUASIMODO group. Radiother Oncol 76(3):354–361CrossRef Bohsung J, Gillis S, Arrans R, Bakai A, De Wagter C, Knöös T et al (2005) IMRT treatment planning—a comparative inter-system and inter-centre planning exercise of the ESTRO QUASIMODO group. Radiother Oncol 76(3):354–361CrossRef
23.
Zurück zum Zitat Ouyang Z, Shen ZL, Murray E, Kolar M, LaHurd D, Yu N et al (2019) Evaluation of auto-planning in IMRT and VMAT for head and neck cancer. J Appl Clin Med Phys 20(7):39–47CrossRef Ouyang Z, Shen ZL, Murray E, Kolar M, LaHurd D, Yu N et al (2019) Evaluation of auto-planning in IMRT and VMAT for head and neck cancer. J Appl Clin Med Phys 20(7):39–47CrossRef
24.
Zurück zum Zitat Nawa K, Haga A, Nomoto A, Sarmiento RA, Shiraishi K, Yamashita H et al (2017) Evaluation of a commercial automatic treatment planning system for prostate cancers. Med Dosim 42(3):203–209CrossRef Nawa K, Haga A, Nomoto A, Sarmiento RA, Shiraishi K, Yamashita H et al (2017) Evaluation of a commercial automatic treatment planning system for prostate cancers. Med Dosim 42(3):203–209CrossRef
25.
Zurück zum Zitat Gintz D, Latifi K, Caudell J, Nelms B, Zhang G, Moros E et al (2016) Initial evaluation of automated treatment planning software. J Appl Clin Med Phys 17(3):331–346CrossRef Gintz D, Latifi K, Caudell J, Nelms B, Zhang G, Moros E et al (2016) Initial evaluation of automated treatment planning software. J Appl Clin Med Phys 17(3):331–346CrossRef
26.
Zurück zum Zitat Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A (2011) Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol 84(1007):967–996CrossRef Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A (2011) Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol 84(1007):967–996CrossRef
27.
Zurück zum Zitat Marrazzo L, Meattini I, Arilli C, Calusi S, Casati M, Talamonti C et al (2019) Auto-planning for VMAT accelerated partial breast irradiation. Radiother Oncol 132:85–92CrossRef Marrazzo L, Meattini I, Arilli C, Calusi S, Casati M, Talamonti C et al (2019) Auto-planning for VMAT accelerated partial breast irradiation. Radiother Oncol 132:85–92CrossRef
28.
Zurück zum Zitat McNiven AL, Sharpe MB, Purdie TG (2010) A new metric for assessing IMRT modulation complexity and plan deliverability. Med Phys 37(2):505–515CrossRef McNiven AL, Sharpe MB, Purdie TG (2010) A new metric for assessing IMRT modulation complexity and plan deliverability. Med Phys 37(2):505–515CrossRef
29.
Zurück zum Zitat LoSasso T, Chui CS, Ling CC (1998) Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy. Med Phys 25(10):1919–1927CrossRef LoSasso T, Chui CS, Ling CC (1998) Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy. Med Phys 25(10):1919–1927CrossRef
30.
Zurück zum Zitat Masi L, Doro R, Favuzza V, Cipressi S, Livi L (2013) Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy. Med Phys 40(7):71718CrossRef Masi L, Doro R, Favuzza V, Cipressi S, Livi L (2013) Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy. Med Phys 40(7):71718CrossRef
31.
Zurück zum Zitat Craft D, Süss P, Bortfeld T (2007) The tradeoff between treatment plan quality and required number of monitor units in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 67(5):1596–1605CrossRef Craft D, Süss P, Bortfeld T (2007) The tradeoff between treatment plan quality and required number of monitor units in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 67(5):1596–1605CrossRef
32.
Zurück zum Zitat Creemers IH, Kusters JM, van Kollenburg PG, Bouwmans LC, Schinagl DA, Bussink J (2019) Comparison of dose metrics between automated and manual radiotherapy planning for advanced stage non-small cell lung cancer with volumetric modulated arc therapy. Phys Imag Radiat Oncol 9:92–96CrossRef Creemers IH, Kusters JM, van Kollenburg PG, Bouwmans LC, Schinagl DA, Bussink J (2019) Comparison of dose metrics between automated and manual radiotherapy planning for advanced stage non-small cell lung cancer with volumetric modulated arc therapy. Phys Imag Radiat Oncol 9:92–96CrossRef
Metadaten
Titel
Evaluation of automatic VMAT plans in locally advanced nasopharyngeal carcinoma
verfasst von
Quanbin Zhang
Liya Ou
Yingying Peng
Hui Yu
Linjing Wang
Shuxu Zhang
Publikationsdatum
02.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 3/2021
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-020-01631-x

Weitere Artikel der Ausgabe 3/2021

Strahlentherapie und Onkologie 3/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.